The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction.

Autor:	Fiori G; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy. ginevrafiori@hotmail.com., Marzi T; Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Italy., Bartoli F; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Bruni C; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Ciceroni C; Veterinary Service of Azienda Sanitaria Locale 10, Florence, Italy., Palomba M; Italian Association 'Utilizzo Cani D'Assistenza' (AIUCA society), Italy., Zolferino M; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Corsi E; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Galimberti M; Italian Association 'Utilizzo Cani D'Assistenza' (AIUCA society), Italy., Moggi Pignone A; Department of Experimental and Clinical Medicine, University of Florence, and Department of Emergency Medicine, Division of Medicine, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Viggiano MP; Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Italy., Guiducci S; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Calamai M; General Director of the Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Matucci-Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology & Scleroderma Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
Jazyk:	angličtina
Zdroj:	Clinical and experimental rheumatology [Clin Exp Rheumatol] 2018 Jul-Aug; Vol. 36 Suppl 113 (4), pp. 135-141. Date of Electronic Publication: 2018 Sep 20.
Abstrakt:	Objectives: The aim of our study was to evaluate the effect of animal-assisted intervention (AAI), a complementary support to traditional therapies focused on the interaction between animals and human beings, in improving psychological trait, anxiety and pain in a cohort of systemic sclerosis (SSc) patients. Methods: 42 SSc patients, undergoing iloprost intravenous infusion, were divided in three groups: 1) 14 patients submitted to 20 AAI sessions; 2) 14 patients engaged in alternative social activity (control group 1 - C1); and 3) 14 patients without any alternative activity (control group 2 - C2). All patients underwent Visual Analog Scale (VAS), the State-anxiety (STAI-S) and emotional faces at the beginning (s0) and at the end (s1) of each single session, while General Anxiety State-Trait Anxiety Inventory (STAI-T), Beck Depression Inventory (BDI), Social Interaction Anxiety Scale (SIAS), Eysenck Personality Questionnaire-Revised (EPQ-R), the Social Phobia Scale (SPS), the Toronto Alexythymia Scale (TAS-20), the Thought Control Questionnaire (TCQ) were administered at baseline (t0) and at the end of the project (t1). Results: AAI group showed a significant decrease of the anxiety state level in respect to the two control groups (p<0.001). VAS scale resulted lower both in AAI (p < 0.001) and C1 group (p<0.01). Moreover, STAI-T and TAS scores were significantly reduced in AAI group (p<0.001). TCQ scale showed that patients treated with AAI, compared to control group C2, had greater capacity to avoid unpleasant and unwanted thoughts (p<0.05). In AAI group, the EPQ-R test revealed an enhancement of extroversion trait compared to both control groups (p<0.05). Conclusions: Our data show that AAI significantly reduces pain perception, anxiety, neuroticism and ameliorates patients' social interaction, therefore it may be a useful to allow a better compliance to traditional therapies.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu